IL113252A0 - Eph receptors binding ligands - Google Patents

Eph receptors binding ligands

Info

Publication number
IL113252A0
IL113252A0 IL11325295A IL11325295A IL113252A0 IL 113252 A0 IL113252 A0 IL 113252A0 IL 11325295 A IL11325295 A IL 11325295A IL 11325295 A IL11325295 A IL 11325295A IL 113252 A0 IL113252 A0 IL 113252A0
Authority
IL
Israel
Prior art keywords
binding ligands
eph receptors
receptors binding
ligands
novel
Prior art date
Application number
IL11325295A
Other languages
English (en)
Original Assignee
Regeneration Pharmaceuticals I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27499262&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL113252(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/299,567 external-priority patent/US5747033A/en
Application filed by Regeneration Pharmaceuticals I filed Critical Regeneration Pharmaceuticals I
Publication of IL113252A0 publication Critical patent/IL113252A0/xx
Priority to IL13564900A priority Critical patent/IL135649A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
IL11325295A 1994-04-04 1995-04-04 Eph receptors binding ligands IL113252A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL13564900A IL135649A0 (en) 1994-04-04 2000-04-13 Biologically active eph family ligand

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US22207594A 1994-04-04 1994-04-04
US22940294A 1994-04-12 1994-04-12
US08/299,567 US5747033A (en) 1993-10-28 1994-09-01 Method of enhancing the biological activity of Eph family ligands
US32742394A 1994-10-21 1994-10-21

Publications (1)

Publication Number Publication Date
IL113252A0 true IL113252A0 (en) 1995-07-31

Family

ID=27499262

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11325295A IL113252A0 (en) 1994-04-04 1995-04-04 Eph receptors binding ligands

Country Status (9)

Country Link
EP (1) EP0758381B2 (fr)
JP (1) JP3686084B2 (fr)
AT (1) ATE232901T1 (fr)
AU (1) AU691915B2 (fr)
CA (1) CA2187167A1 (fr)
DE (1) DE69529674T3 (fr)
ES (1) ES2192199T5 (fr)
IL (1) IL113252A0 (fr)
WO (1) WO1995027060A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824303A (en) 1992-11-13 1998-10-20 Amgen Inc. Eck receptor ligands
US5624899A (en) * 1994-07-20 1997-04-29 Genentech Inc. Method for using Htk ligand
ATE263781T1 (de) * 1994-10-27 2004-04-15 Genentech Inc Neurotrophischer al-1 faktor, einer ligand verwant mit dem eph tyrosine kinase receptor
US5759775A (en) * 1994-10-27 1998-06-02 Genetech, Inc. Methods for detecting nucleic acids encoding AL--1 neurotrophic factor
JPH11515105A (ja) * 1995-10-13 1999-12-21 マウント・サイナイ・ホスピタル・コーポレイション 新規リガンド調節経路の活性化方法
US6610296B2 (en) 1995-10-26 2003-08-26 Genentech, Inc. Methods of enhancing cognitive function using an AL-1 neurotrophic factor immunoadhesin
US6696557B1 (en) * 1996-04-19 2004-02-24 Genentech, Inc. AL-2 neurotrophic factor nucleic acid
CA2259157A1 (fr) * 1996-07-05 1998-01-15 Mount Sinai Hospital Corporation Recepteurs oligomerises modulant des voies regulees par des ligands transmembranaires pour des recepteurs tyrosine-kinases type elk
US5994112A (en) * 1996-10-09 1999-11-30 Incyte Pharmaceuticals, Inc. Human protein tyrosine kinase
CA2355163A1 (fr) * 1998-12-18 2000-06-29 Mount Sinai Hospital Structure tridimensionnelle d'un domaine de motif alpha sterile
EP1141294B1 (fr) * 1998-12-23 2005-03-02 Regeneron Pharmaceuticals, Inc. Technique permettant d'accroitre l'activite biologique de ligands
EP2789630A1 (fr) 2013-04-09 2014-10-15 EngMab AG Anticorps bispécifiques contre le CD3e et ROR1
EP3204415B1 (fr) 2014-10-09 2020-06-17 EngMab Sàrl Anticorps bispécifiques contre cd3epsilon et ror1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5151360A (en) * 1990-12-31 1992-09-29 Biomembrane Institute Effect of n,n,n-trimethylsphingosine on protein kinase-c activity, melanoma cell growth in vitro, metastatic potential in vivo and human platelet aggregation
JPH08505765A (ja) * 1992-11-13 1996-06-25 アムジエン・インコーポレーテツド Ｅｃｋ受容体リガンド
JP3560609B2 (ja) * 1992-11-13 2004-09-02 イミュネックス・コーポレーション Ｅｌｋリガンドと呼ばれる新規なサイトカイン
US5516658A (en) * 1993-08-20 1996-05-14 Immunex Corporation DNA encoding cytokines that bind the cell surface receptor hek

Also Published As

Publication number Publication date
DE69529674D1 (de) 2003-03-27
AU2278995A (en) 1995-10-23
JPH09511401A (ja) 1997-11-18
DE69529674T2 (de) 2003-12-18
ATE232901T1 (de) 2003-03-15
WO1995027060A3 (fr) 1995-11-02
AU691915B2 (en) 1998-05-28
ES2192199T3 (es) 2003-10-01
DE69529674T3 (de) 2007-06-28
ES2192199T5 (es) 2007-07-01
JP3686084B2 (ja) 2005-08-24
EP0758381A1 (fr) 1997-02-19
EP0758381B1 (fr) 2003-02-19
CA2187167A1 (fr) 1995-10-12
EP0758381B2 (fr) 2006-11-15
WO1995027060A2 (fr) 1995-10-12

Similar Documents

Publication Publication Date Title
IL113252A0 (en) Eph receptors binding ligands
IL142905A0 (en) Functional antagonists of hedgehog activity
MX9605365A (es) Fracciones polipeptidicas solubles de la proteina lag-3; procedimiento de produccion; composicion terapeutica y anticuerpos ant-idiotipo.
CA2095153A1 (fr) Modification genetique de cellules endotheliales
UA29494C2 (uk) Гуманізовані антитіла, способи їх продукування, спосіб лікування хвороби крона, спосіб лікування розсіяного склерозу, фармацевтична композиція
BG103091A (en) Shortened soluble receptors of type i & ii of the tumour necrotizing factor
CY1107821T1 (el) Πολυπεπτιδιο παραγοντα viii με ενεργοτητα παραγοντα viii:c
HU9202073D0 (en) Antibody-antagonists of human interleucin-4
IL193886A0 (en) Antibodies that bind to ldcam sequences
WO2000053761A3 (fr) Nouvelle cytokine: le ligand zalpha11
WO2001077171A3 (fr) Recepteurs de cytokines zalpha11 solubles
BG102817A (en) Modulators of factor traf asociated with tnf-receptor, their preparation and application
ES8504938A1 (es) Un metodo de producir una proteina interferon inmune humano
EP0515516A4 (en) Totally synthetic affinity reagents
WO2002012345A3 (fr) Recepteurs de cytokines zcytor 11 solubles
ES8606494A1 (es) Un metodo de producir un peptido o polipeptido sintetico.
HK1040093A1 (en) Method of enhancing the biological activity of ligands.
DE69712124D1 (de) Hormones de croissance humaines mutantes et leur utilisation
AU7477896A (en) Biologically active eph family ligands
IL127363A0 (en) IL-1/TNF-alpha-activated kinase and methods of making and using the same
CA2236001A1 (fr) Ligands biologiquement actifs de la famille des eph
MXPA02011938A (es) Adn que codifica para un receptor de histamina de mamifero del subtipo h4.
ES2033212A6 (es) Procedimiento para la obtencion de peptidos puramente glicosilados, parcialmente glicosilados o no glicosilados.
MY134493A (en) Thrombopoietin peptides, fragments, nucleic acids encoding the same, and method
UA35624C2 (uk) МОЛЕКУЛА ДНК, ЩО КОДУЄ ПРОТЕЇН TGF-<font face="Symbol">b</font>-РОДИНИ, ВЕКТОР, L-КЛІТИНА, ПРОТЕЇН TGF-<font face="Symbol">b</font>-РОДИНИ, СПОСІБ ЙОГО ОТРИМАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, МОНОКЛОНАЛЬНЕ АНТИТІЛО

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees